We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Noninvasive and Reagent-Free Technique Uses Raman Spectroscopy and Machine Learning for Detection of COVID-19

By LabMedica International staff writers
Posted on 10 Feb 2022
Print article
Image: Machine-learning model (Photo courtesy of Ember et al., doi 10.1117/1.JBO.27.2.025002)
Image: Machine-learning model (Photo courtesy of Ember et al., doi 10.1117/1.JBO.27.2.025002)

Researchers have developed a new and improved method that uses Raman spectroscopy and machine learning for the detection of SARS-CoV-2.

The noninvasive and reagent-free technique for the efficient detection of COVID-19 has been developed by biomedical researchers at Polytechnique Montréal (Montreal, Canada). Reverse transcription polymerase chain reaction (RT-PCR) techniques are currently the gold standard for detecting SARS-COV-2, the virus that causes COVID-19, although they have certain limitations. RT-PCR involves the transportation of samples to a clinical laboratory for testing, which poses logistical difficulties. It also requires the use of reagents, which could be in short supply and may be less effective when the virus mutates. Moreover, RT-PCR tests can be time-consuming and less sensitive in asymptomatic individuals, rendering them unfeasible for widespread rapid screening. Hence, researchers are trying to devise novel methods for better detection of COVID-19 infections in point-of-care settings, without the need to send away samples for testing.

The new reagent-free detection technique that is based on machine learning and laser-based Raman spectroscopy uses saliva samples. Unlike nasopharyngeal swabs, saliva sampling is safer and noninvasive. Raman spectroscopy is routinely used by researchers to determine the molecular composition of samples. Put simply, molecules scatter incident photons (particles of light) in a unique manner that is dependent on underlying chemical structures and bonding. Researchers can sense and identify molecules based on their characteristic Raman "fingerprint" or spectrum, which is obtained by shining light at samples and measuring the scattered light.

COVID-19 can cause chemical changes in the composition of saliva. Based on this knowledge, the research team analyzed 33 COVID-19-positive samples clinically matched with a subset of a total 513 COVID-19-negative saliva samples. The Raman spectra they obtained were then trained on multiple-instance learning models, instead of conventional ones. The results from this method indicate an accuracy of about 80%, and the researchers found that taking sex at birth into consideration was important in achieving this accuracy. Although saliva composition is affected by time of day as well as the age of the test subject and other underlying health conditions, this technique can still prove to be a great candidate for real-world COVID-19 detection. These findings can facilitate better COVID-19 detection in addition to paving the way for new tools for other infectious diseases.

"Our label-free approach overcomes many limitations of RT-PCR testing. We are working to commercialize this as a faster, robust, and low-cost system, with potentially higher accuracy," said Katherine Ember, a postdoctoral researcher at Polytechnique Montréal, Canada, and first author of the study. "This could be easily integrated with current viral detection workflows, adapted to new viruses and bacterial infections, as well as accounting for confounding variables through new machine learning approaches. In parallel, we are working on reducing the testing time further by using nanostructured metallic surfaces for containing the saliva sample."

Related Links:
Polytechnique Montréal 

New
Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.